Evidence map›Paper›PMID 37653887›Full record

ReviewPlants (Basel, Switzerland)2023

Anti-Cancer Agent: The Labdane Diterpenoid-Andrographolide.

Rosa Tundis, Jayanta Kumar Patra, Marco Bonesi, Subrata Das, Rajat Nath, Anupam Das Talukdar, Gitishree Das, Monica Rosa Loizzo

Abstract readReview
In one paragraph

Review in Plants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. An Innovative Method of Improving an Extract ofInternational journal of molecular sciences · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rosa TundisDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.ORCID 0000-0002-3713-4403
Jayanta Kumar PatraResearch Institute of Integrative Life Sciences, Dongguk University-Seoul, Goyangsi 10326, Republic of Korea.ORCID 0000-0003-4118-4355
Marco BonesiDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.
Subrata DasDepartment of Botany and Biotechnology, Karimganj College, Assam University, Assam 788710, India.
Rajat NathDepartment of Life Science and Bioinformatics, Assam University, Assam 788011, India.ORCID 0000-0002-6633-8122
Anupam Das TalukdarDepartment of Life Science and Bioinformatics, Assam University, Assam 788011, India.
Gitishree DasResearch Institute of Integrative Life Sciences, Dongguk University-Seoul, Goyangsi 10326, Republic of Korea.ORCID 0000-0002-5676-0768
Monica Rosa LoizzoDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.ORCID 0000-0002-6050-9357

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In spite of the progress in treatment strategies, cancer remains a major cause of death worldwide. Therefore, the main challenge should be the early diagnosis of cancer and the design of an optimal therapeutic strategy to increase the patient's life expectancy as well as the continuation of the search for increasingly active and selective molecules for the treatment of different forms of cancer. In the recent decades, research in the field of natural compounds has increasingly shifted towards advanced and molecular level understandings, thus leading to the development of potent anti-cancer agents. Among them is the diterpene lactone andrographolide, isolated from

Indexed as

angiogenesisapoptosisautophagycancerenhanced radio-sensitivitymechanism of action

Identifiers

PMID37653887
PMCPMC10221142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.